HK1149003A1 - 4-aminopyrimidine derivatives as histamine h4 receptor antagonists - Google Patents

4-aminopyrimidine derivatives as histamine h4 receptor antagonists

Info

Publication number
HK1149003A1
HK1149003A1 HK11103050.8A HK11103050A HK1149003A1 HK 1149003 A1 HK1149003 A1 HK 1149003A1 HK 11103050 A HK11103050 A HK 11103050A HK 1149003 A1 HK1149003 A1 HK 1149003A1
Authority
HK
Hong Kong
Prior art keywords
histamine
receptor antagonists
aminopyrimidine derivatives
aminopyrimidine
derivatives
Prior art date
Application number
HK11103050.8A
Other languages
English (en)
Inventor
Gonzalez Elena Carceller
Fuentes Eva Maria Medina
Soliva Robert Soliva
Bernado Marina Virgili
Via Josep Marti
Original Assignee
Palau Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palau Pharma Sa filed Critical Palau Pharma Sa
Publication of HK1149003A1 publication Critical patent/HK1149003A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK11103050.8A 2007-12-21 2011-03-25 4-aminopyrimidine derivatives as histamine h4 receptor antagonists HK1149003A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07382006 2007-12-21
US3153408P 2008-02-26 2008-02-26
PCT/EP2008/067950 WO2009080721A2 (en) 2007-12-21 2008-12-18 4 -aminopyrimidine derivatives as histamine h4 receptor antagonists

Publications (1)

Publication Number Publication Date
HK1149003A1 true HK1149003A1 (en) 2011-09-23

Family

ID=39473347

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103050.8A HK1149003A1 (en) 2007-12-21 2011-03-25 4-aminopyrimidine derivatives as histamine h4 receptor antagonists

Country Status (25)

Country Link
US (1) US8431580B2 (zh)
EP (1) EP2235012B1 (zh)
JP (1) JP5498396B2 (zh)
KR (1) KR101639819B1 (zh)
CN (1) CN101903385B (zh)
AR (1) AR069814A1 (zh)
AU (1) AU2008341678B2 (zh)
BR (1) BRPI0820779B8 (zh)
CA (1) CA2709650C (zh)
CL (1) CL2008003811A1 (zh)
CY (1) CY1114427T1 (zh)
DK (1) DK2235012T3 (zh)
ES (1) ES2430210T3 (zh)
HK (1) HK1149003A1 (zh)
HR (1) HRP20130918T1 (zh)
IL (1) IL206413A (zh)
PE (1) PE20091330A1 (zh)
PL (1) PL2235012T3 (zh)
PT (1) PT2235012E (zh)
RU (1) RU2489430C2 (zh)
SI (1) SI2235012T1 (zh)
TW (1) TWI429440B (zh)
UA (1) UA101963C2 (zh)
WO (1) WO2009080721A2 (zh)
ZA (1) ZA201005179B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007026341A1 (de) 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
DE102007032507A1 (de) 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
DE102007061963A1 (de) 2007-12-21 2009-06-25 Merck Patent Gmbh Pyridazinonderivate
DE102008019907A1 (de) 2008-04-21 2009-10-22 Merck Patent Gmbh Pyridazinonderivate
DE102008028905A1 (de) 2008-06-18 2009-12-24 Merck Patent Gmbh 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
AU2009331990B2 (en) 2008-12-22 2016-04-14 Merck Patent Gmbh Novel polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
EP2201982A1 (en) 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
RU2553681C2 (ru) 2009-10-29 2015-06-20 Вектура Лимитед N-содержащие гетероарильные производные в качестве ингибиторов jak3 киназы
UA107818C2 (en) 2009-12-23 2015-02-25 Medicis Pharmaceutical Corp Usa Alkyl amino pyrimidine derivatives as antagonists district h4-histamine receptors
JP6185574B2 (ja) 2012-06-08 2017-08-23 センソリオン 耳鳴りを治療するためのｈ４受容体阻害剤
TWI797176B (zh) * 2017-10-17 2023-04-01 西班牙商帕羅製藥有限公司 ４-胺基嘧啶化合物之合成

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2361869C2 (ru) * 2002-02-05 2009-07-20 ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Новые арил- и гетероарилпиперазины
EP1505064A1 (en) * 2003-08-05 2005-02-09 Bayer HealthCare AG 2-Aminopyrimidine derivatives
WO2005054239A1 (en) * 2003-12-05 2005-06-16 Bayer Healthcare Ag 2-aminopyrimidine derivatives
EA010568B1 (ru) * 2003-12-15 2008-10-30 Ньюрокрайн Байосайнсиз Инк. 2,6-бисгетероарил-4-аминопиримидины в качестве антагонистов аденозиновых рецепторов
DE602006020864D1 (de) * 2005-04-11 2011-05-05 Almirall Sa 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten
US20090306038A1 (en) * 2005-09-13 2009-12-10 Carceller Gonzalez Elena 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
WO2007084914A2 (en) * 2006-01-17 2007-07-26 Neurocrine Biosciences, Inc. Phenoxy-substituted pyrimidines as adenosine receptor antagonists

Also Published As

Publication number Publication date
PL2235012T3 (pl) 2013-12-31
AU2008341678A1 (en) 2009-07-02
BRPI0820779B8 (pt) 2021-05-25
HRP20130918T1 (hr) 2013-11-08
CN101903385B (zh) 2013-11-06
SI2235012T1 (sl) 2013-11-29
BRPI0820779A2 (pt) 2015-06-16
ZA201005179B (en) 2012-03-28
US20110039817A1 (en) 2011-02-17
KR20100096184A (ko) 2010-09-01
DK2235012T3 (da) 2013-10-07
EP2235012B1 (en) 2013-07-17
US8431580B2 (en) 2013-04-30
KR101639819B1 (ko) 2016-07-14
IL206413A (en) 2015-06-30
IL206413A0 (en) 2010-12-30
CL2008003811A1 (es) 2009-05-22
BRPI0820779B1 (pt) 2020-02-04
CY1114427T1 (el) 2016-08-31
PE20091330A1 (es) 2009-09-07
EP2235012A2 (en) 2010-10-06
AR069814A1 (es) 2010-02-17
TWI429440B (zh) 2014-03-11
AU2008341678B2 (en) 2013-03-21
RU2489430C2 (ru) 2013-08-10
JP2011506566A (ja) 2011-03-03
PT2235012E (pt) 2013-08-28
CN101903385A (zh) 2010-12-01
WO2009080721A3 (en) 2009-09-11
RU2010130418A (ru) 2012-01-27
JP5498396B2 (ja) 2014-05-21
ES2430210T3 (es) 2013-11-19
TW200938197A (en) 2009-09-16
CA2709650C (en) 2016-06-07
WO2009080721A2 (en) 2009-07-02
UA101963C2 (en) 2013-05-27
CA2709650A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
HK1149003A1 (en) 4-aminopyrimidine derivatives as histamine h4 receptor antagonists
MX2009003316A (es) Derivados de pirazina-2-carboxamida como moduladores receptores de cb2.
TW200800956A (en) 2-Aminopyrimidine derivatives
ATE496051T1 (de) Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten
ATE483707T1 (de) 2-cyclopropylthiazolderivate
PL2069332T3 (pl) Związki azetydynowe jako antagoniści receptorów oreksynowych
ATE469895T1 (de) Cgrp-rezeptorantagonisten
MY160490A (en) Arylethynyl derivatives
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
DOP2007000068A (es) Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2
MX2009009690A (es) Derivados de tiazolidina como antagonistas del receptor de orexina.
TW200740814A (en) Compounds
MX2009009415A (es) Compuestos de tetrahidroisoquinolina como moduladores del receptor h3 de la histamina.
MY146506A (en) Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
MY147649A (en) Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders
MX2010008713A (es) Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii.
MXPA05013149A (es) Derivados de imidazol como antagonistas del receptor de glutamato.
HK1124842A1 (en) Methods of preparing imidazole-based compounds
MA32834B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
MX2009010176A (es) Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
MX2010005488A (es) Compuestos de cicloalquiloxi y heterocicloalquiloxipiridina como moduladores del receptor h3 de histamina.
WO2008153902A3 (en) Urotensin ii receptor antagonists
MX345142B (es) Derivados de aminoalquilpirimidina como antagonistas del receptor h4 de histamina.
TNSN07462A1 (en) Ampa receptor potentiators
TW200745110A (en) Naphthyridin derivatives